Source: International Congress 2017 – Translational studies of lung disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. van der Does (Leiden, Netherlands). Disturbed fatty acid metabolism in airway secretions of patients with Chronic Obstructive Pulmonary Disease. 3913

Member's Comments

No comment yet.

Related content which might interest you: Effect of smoking on the specific cholinergic hypersensitivity of airways in patients with Chronic Obstructive Pulmonary Disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 178s Year: 2002 Effect of roflumilast on cytokines levels in patients with Chronic Obstructive Pulmonary Disease Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science Year: 2021 “Asthma-like features” in Chronic Obstructive Pulmonary Disease (COPD) patients Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 Pathogenic bacteria for exacerbation of Chronic Obstructive Pulmonary Disease Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 Chronic obstructive pulmonary disease (COPD) and alterations of hemogram Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Putative role of Eosinophilic cells in Chronic Obstructive Pulmonary Disease (COPD) Source: International Congress 2017 – Translational studies of lung disease Year: 2017 Metabolic paralysis in systemic immune cells of Chronic Obstructive Pulmonary Disease (COPD) subjects. Source: International Congress 2018 – Functional genomics and COPD: new challenges Year: 2018 Chronic Obstructive Pulmonary Disease Exacerbations Source: Eur Respir Rev 2009; 18: 305 Year: 2009 Impact of non-alcoholic fatty liver disease on late cardiovascular events and death in Chronic Obstructive Pulmonary Disease Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 Association of serum uric acid levels and outcomes of patients with Chronic Obstructive Pulmonary Disease (COPD) Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Chronic Obstructive Pulmonary Disease (COPD) Source: Eur Respir Rev 2009; 18: 133 Year: 2009 Low Level of  Airway Mucin 2 Predict Severe Exacerbations in Patients with Severe Chronic Obstructive Pulmonary Disease Source: International Congress 2017 – COPD biomarkers Year: 2017 The metabolic syndrome in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Determinants of Airflow Limitation in Chronic Obstructive Pulmonary Disease Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair Year: 2020 Chronic Obstructive Pulmonary Disease (COPD) patients with airway eosinophilic inflammation are characterized by lower functional impairment. Source: International Congress 2019 – Airway diseases and blood cells Year: 2019 Effectiveness of pulmonary rehabilitation initiated after exacerbation of Chronic Obstructive Pulmonary Disease Source: International Congress 2018 – Aspects of pulmonary rehabilitation and chronic care Year: 2018 Effects of a self-management program in exacerbated Chronic Obstructive Pulmonary Disease Source: International Congress 2019 – Airway infection in COPD Year: 2019 Association of Metabolic Syndrome with the severity of Chronic Obstructive Pulmonary Disease Source: Virtual Congress 2020 – Clinical data and COPD management Year: 2020 Upper Respiratory Symptoms in Patients with Chronic Obstructive Pulmonary Disease Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD Year: 2020 Sexuality in Chronic Obstructive Pulmonary Disease (SEXY COPD) Source: Virtual Congress 2020 – Comprehensive care and pulmonary rehabilitation for chronic respiratory diseases Year: 2020